Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Véronique Baldin is active.

Publication


Featured researches published by Véronique Baldin.


International Journal of Cancer | 1998

Increased level of p21 in human ovarian tumors is associated with increased expression of CDK2, cyclin A and PNCA

Nadia Barboule; Véronique Baldin; Suzanne Jozan; Simone Vidal; Annie Valette

We have demonstrated over‐expression of the cyclin‐dependent kinase inhibitor p21 in various ovarian‐cancer cell lines as well as in ovarian‐tumor biopsies. This increase in p21 expression relative to that observed in normal ovarian epithelial cells is unrelated to proliferation index. In the present study, we found that p21 is functional, since the protein extracted from IGROV1 cells is still able to inhibit cdk2‐kinase activity. We then investigated how IGROV1 cells overcome the growth‐inhibitory function of p21. Immunofluorescence assays and subcellular fractionation showed that p21 is located in cytoplasm and nucleus both in normal and in tumoral cells. Compared with normal ovarian epithelial cells in culture, the increase in level of p21 in IGROV1 cells was found to be associated with increased expression of cdk2, cyclin‐A and PCNA proteins. In IGROV1 cells, p21 is associated with inactive cdk2/cyclin‐A complex, indicating that it acts as an inhibitory factor rather than an assembly factor. Over‐expression of cdk2 and of cyclin A observed in IGROV1 cells allows them to escape to p21‐inhibitory activity. The fact that cells from ovarian‐tumor biopsies exhibited a concomitant increase in p21 and in its partners cdk2 and PCNA suggest that ovarian‐tumor cells can tolerate high levels of functional p21 via over‐expression of other cell‐cycle‐regulatory proteins. Int. J. Cancer 76:891–896, 1998.© 1998 Wiley‐Liss, Inc.


Molecular Biology of the Cell | 2008

A Novel Role for PA28γ-Proteasome in Nuclear Speckle Organization and SR Protein Trafficking

Véronique Baldin; Muriel Militello; Yann Thomas; Christine M. Doucet; Weronika Fic; Stéphanie Boireau; Isabelle Jariel-Encontre; Marc Piechaczyk; Edouard Bertrand; Jamal Tazi; Olivier Coux

In eukaryotic cells, proteasomes play an essential role in intracellular proteolysis and are involved in the control of most biological processes through regulated degradation of key proteins. Analysis of 20S proteasome localization in human cell lines, using ectopic expression of its CFP-tagged alpha7 subunit, revealed the presence in nuclear foci of a specific and proteolytically active complex made by association of the 20S proteasome with its PA28gamma regulator. Identification of these foci as the nuclear speckles (NS), which are dynamic subnuclear structures enriched in splicing factors (including the SR protein family), prompted us to analyze the role(s) of proteasome-PA28gamma complexes in the NS. Here, we show that knockdown of these complexes by small interfering RNAs directed against PA28gamma strongly impacts the organization of the NS. Further analysis of PA28gamma-depleted cells demonstrated an alteration of intranuclear trafficking of SR proteins. Thus, our data identify proteasome-PA28gamma complexes as a novel regulator of NS organization and function, acting most likely through selective proteolysis. These results constitute the first demonstration of a role of a specific proteasome complex in a defined subnuclear compartment and suggest that proteolysis plays important functions in the precise control of splicing factors trafficking within the nucleus.


Biochimica et Biophysica Acta | 1990

Glucocorticoids repress ribosome biosynthesis in lymphosarcoma cells by affecting gene expression at the level of transcription, posttranscription and translation

Oded Meyuhas; Véronique Baldin; Gérard Bouche; François Amalric

Growth arrest of P1798 murine lymphosarcoma cells by glucocorticoids is accompanied by a remarkable decrease in transcription of rRNA and translation of mRNAs encoding basic ribosomal proteins (rps). Here we report that the expression of other genes involved in ribosome biogenesis is repressed in dexamethasone-treated P1798 cells. These include posttranscriptionally regulated decline in the abundance of the mRNA and primary transcript of nucleolin; abrupt drop in the transcription rate of U3 small nucleolar RNA; and inhibition of translation of mRNAs coding for P2 and L5, acidic and basic rps, respectively. Normal expression of these genes is resumed upon hormonal withdrawal.


Molecular and Cellular Biology | 2008

JunB Breakdown in Mid-/Late G2 Is Required for Down-Regulation of Cyclin A2 Levels and Proper Mitosis

Rosa Farràs; Véronique Baldin; Sandra Gallach; Claire Acquaviva; Guillaume Bossis; Isabelle Jariel-Encontre; Marc Piechaczyk

ABSTRACT JunB, a member of the AP-1 family of dimeric transcription factors, is best known as a cell proliferation inhibitor, a senescence inducer, and a tumor suppressor, although it also has been attributed a cell division-promoting activity. Its effects on the cell cycle have been studied mostly in G1 and S phases, whereas its role in G2 and M phases still is elusive. Using cell synchronization experiments, we show that JunB levels, which are high in S phase, drop during mid- to late G2 phase due to accelerated phosphorylation-dependent degradation by the proteasome. The forced expression of an ectopic JunB protein in late G2 phase indicates that JunB decay is necessary for the subsequent reduction of cyclin A2 levels in prometaphase, the latter event being essential for proper mitosis. Consistently, abnormal JunB expression in late G2 phase entails a variety of mitotic defects. As these aberrations may cause genetic instability, our findings contrast with the acknowledged tumor suppressor activity of JunB and reveal a mechanism by which the deregulation of JunB might contribute to tumorigenesis.


Protein Expression and Purification | 2009

High yield bacterial expression and purification of active recombinant PA28αβ complex

Aurélie Y. Le Feuvre; Carmela Dantas-Barbosa; Véronique Baldin; Olivier Coux

The PA28 complexes (also termed REG or 11S complexes) are described as activators of the 20S proteasome, a major intracellular protease in eukaryotic cells. They bind to the ends of the barrel-shaped 20S proteasome, and activate its peptidase activities. The interferon gamma inducible PA28alphabeta, made of the two related subunits PA28alpha and beta, is under sustained investigation as it plays important roles in the production by the proteasome of class I antigen peptides. However, in vitro studies of this complex have been impaired by the difficulty of producing large amount of this protein, mainly due to the poor solubility of its beta subunit when expressed in Escherichia coli. Here we describe the construction of a bicistronic vector, allowing simultaneous production of functional human PA28alpha and beta subunits in E. coli. Co-expression of the two proteins allows efficient formation of active PA28alphabeta complexes, that remain soluble and can be easily purified by regular chromatographic procedures.


Biology of the Cell | 1996

REGULATION OF p21WAF1/CIP1 EXPRESSION IN HUMAN OVARIAN CARCINOMA

Nadia Barboule; Philippe Mazars; Véronique Baldin; Simone Vidal; Suzanne Jozan; Annie Valette

BODART Jean-Francois’, FLAMENT..&?phanc’. BROWAEYS Edith’. BERTOUT ~arcl, ROUSSEAU Arlettel, GANNON Julian2 et VILAIN Jean-Pierrel. 1 Centre de Biologie Cellulaire, Unit6 de Dynamique des cellules embryonnaires et cancereuses, Laboratoire de Biologie du Developpcment. EA DRED 1033, UniversitC de Lille 1, SN3, F-59655 Villeneuve d’Ascq cedex, France. 2 Imperial Cancer Research Fund Clare Hall Laboratories, South Mimms, Hertfordshire EN6 3LD. U.K.


Nucleic Acids Research | 1989

Protein kinase NII and the regulation of rDNA transcription in mammalian cells

Pascale Bclenguer; Véronique Baldin; Colette Mathieu; Hervé Prats; Mohamed Bensaïd; Gérard Bouche; François Amalric


International Journal of Cancer | 1995

Expression of p21WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma

Nadia Barboule; Philippe Mazars; Véronique Baldin; Simone Vidal; Suzanne Jozan; P. Martel; Annie Valette


Annals of the New York Academy of Sciences | 1991

Nuclear translocation of basic fibroblast growth factor.

François Amalric; Véronique Baldin; I. Bosc‐Bierne; Béatrix Bugler; B. Couderc; M. Guyader; V. Patry; H Prats; A. M. Roman; Gérard Bouche


Methods in Enzymology | 1991

Localization of peptide growth factors in the nucleus

Bruno Gabriel; Véronique Baldin; Anna Maria Roman; Isabelle Bosc-Bierne; Jacqueline Noaillac-Depeyre; Hervé Prats; Justin Teissié; Gérard Bouche; François Amalric

Collaboration


Dive into the Véronique Baldin's collaboration.

Top Co-Authors

Avatar

François Amalric

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Gérard Bouche

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Olivier Coux

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Annie Valette

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Nadia Barboule

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Simone Vidal

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Isabelle Jariel-Encontre

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Marc Piechaczyk

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Philippe Mazars

Centre national de la recherche scientifique

View shared research outputs
Researchain Logo
Decentralizing Knowledge